Jubilant Cadista Pharmaceuticals, a drugmaker based in Maryland, is recalling one lot of its drospirenone and ethinyl estradiol birth control tablets over concerns that they might not work properly, the company said this week.
The affected product, which was distributed to wholesalers, suppliers and retailers, is being recalled after the drug didn't meet specifications or acceptance criteria for dissolution, the company said.
"Product efficacy may be decreased due to incomplete absorption of the active ingredients," the recall notice reads.
The affected lot number is 183222, with an expiration date of November 2020.
More articles on pharmacy:
Oklahoma opioid trial wraps: 10 takeaways
Drugmaker tried to shred records before FDA inspection, agency claims
Publix Pharmacy to deliver prescriptions to patients before hospital discharge